Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute ischemic syndromes

R M Califf1

  • 1Databank for Cardiovascular Disease, Duke University Medical Center, Durham, North Carolina, USA.

The Medical Clinics of North America
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Acute ischemic heart disease poses significant public health challenges. This review covers diagnosis, treatment, and cost-effective system organization for acute ischemic syndromes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical, electrocardiographic, and biochemical data for immediate risk stratification in acute coronary syndromes.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·2001
Same author

Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.

The American journal of cardiology·2001
Same author

Introduction: evidence to practice in acute coronary syndromes.

The American journal of cardiology·2001
Same author

Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators.

Journal of the American College of Cardiology·2001
Same author

Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies.

Circulation·2001
Same author

Statistical approaches and policies for the operations of Data and Safety Monitoring Committees.

American heart journal·2001
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Area of Science:

  • Cardiology
  • Public Health
  • Emergency Medicine

Background:

  • Acute ischemic heart disease represents a critical public health concern.
  • Understanding the pathophysiology leading to clinical manifestations is essential.

Purpose of the Study:

  • To review the current knowledge on acute ischemic syndromes.
  • To outline diagnostic criteria and therapeutic interventions.
  • To discuss cost-effective healthcare system organization.

Main Methods:

  • Literature review of current research on acute ischemic syndromes.
  • Synthesis of information on diagnosis and treatment strategies.
  • Analysis of healthcare system organization for acute ischemic heart disease.

Related Experiment Videos

Main Results:

  • Key diagnostic elements for acute ischemic syndromes identified.
  • Therapeutic options impacting patient outcomes detailed.
  • Strategies for cost-effective management and system organization presented.

Conclusions:

  • Effective diagnosis and treatment of acute ischemic heart disease require a comprehensive approach.
  • Optimizing healthcare systems is crucial for managing this public health issue efficiently.